BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 407760)

  • 1. [Studies on antithrombin by TAD method and immunological method].
    Nagata H; Watanabe N; Hasegawa H
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):192-6. PubMed ID: 407760
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.
    Fagerhol MK; Abildgaard U
    Scand J Haematol; 1970; 7(1):10-7. PubMed ID: 4988538
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.
    Moyssakis I; Vlahodimitris IE; Kanakis MA; Kapsimali V; Tsoucala C; Vaiopoulos GA
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):670-3. PubMed ID: 20885133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE).
    Gallus AS; Walker IR; Hirsh J; Halasah G; Evans G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):566. PubMed ID: 1198447
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteration of plasma antithrombin III levels in ischemic heart disease.
    Yue RH; Gertler MM; Starr T; Koutrouby R
    Thromb Haemost; 1976 Jun; 35(3):598-606. PubMed ID: 989967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
    Meguro T; Yamada K; Shirahata A
    Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Pill and antithrombin. Effects of the pill on progressive antithrombin activity and plasmatic concentration of 3 antithrombins].
    Marcel GA; Sabatier C; Casper C; Warniez C
    Nouv Presse Med; 1973 Nov; 2(42):2820-1. PubMed ID: 4773655
    [No Abstract]   [Full Text] [Related]  

  • 10. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: A new antithrombin III assay.
    Lane JL
    Thromb Diath Haemorrh; 1974 Jun; 31(3):517-8. PubMed ID: 4213849
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin and leucocyte procoagulant activity.
    Lancet; 1985 Jun; 1(8442):1396-7. PubMed ID: 2861348
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
    Grimmer O; Fagerhol MK
    Int J Pept Protein Res; 1977; 9(2):85-90. PubMed ID: 402327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-3 in a clinical material.
    Hedner U; Nilsson IM
    Bibl Anat; 1973; 12():267-71. PubMed ID: 4790361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
    Fischer M
    Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
    Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
    J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the blood picture in various types of thromboembolism].
    Krylov AA; Senenko AN
    Sov Med; 1972 Apr; 35(4):137-8. PubMed ID: 4662433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.